Coralie Genevois

Mrs. Coralie Genevois


Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
3 November 2017 in Molecular Systems Design & Engineering
Verified
Journal Article
Closed access
PDF file
GHGauvin Hemery
Gauvin Hemery
CGCoralie Genevois
Coralie Genevois
FCFranck Couillaud
Franck Couillaud
SLSabrina Lacomme
Sabrina Lacomme
EGEtienne Gontier
Etienne Gontier
Olivier SandreOlivier Sandre
Olivier Sandre
PEGylated magnetic iron oxide nanoparticles (IONPs) were synthesised with the aim to provide proof of concept results of remote cancer cell killing by magnetic fluid hyperthermia. The IONPs were produced by the polyol synthetic route also called the “forced hydrolysis pathway”, yielding highly superparamagnetic, readily-dispersible, and biocompatible IONPs. As shown previously, adjusting the parameters of the reaction led to either monocore or multicore IONPs, with an on-demand morphology and magnetic properties. Polyethylene glycol (PEG) was grafted onto the nanoparticles in a single final step, using a phosphonic acid-terminated PEG synthesised separately, a strategy named “convergent”. The magnetic properties of the IONPs were preserved in physiological media, thanks to this biocompatible shell. The interaction of the PEGylated IONPs with a glioblastoma cell line was studied, from the stability of IONPs in an appropriate cell culture medium to the remotely magnetically triggered cell death. Cellular internalisation of the IONPs was studied, along with their fate after application of an alternating magnetic field (AMF). This investigation highlights the superior efficiency of multicore (nanoflowers) vs. monocore (nanospheres) IONPs for magnetic hyperthermia, leading to 80% cancer cell death in medically translatable conditions.

28 April 2017 in Journal of Nanobiotechnology
Verified
Journal Article
Open access
PDF file
AVAnaïs Vaissière
Anaïs Vaissière
GAGudrun Aldrian
Gudrun Aldrian
KKKaridia Konate
Karidia Konate
MLMattias F. Lindberg
Mattias F. Lindberg
CJCarole Jourdan
Carole Jourdan
Sébastien DeshayesSébastien Deshayes
Sébastien Deshayes
Small interfering RNAs (siRNAs) are powerful tools to control gene expression. However, due to their poor cellular permeability and stability, their therapeutic development requires a specific delivery system. Among them, cell-penetrating peptides (CPP) have been shown to transfer efficiently siRNA inside the cells. Recently we developed amphipathic peptides able to self-assemble with siRNAs as peptide-based nanoparticles and to transfect them into cells. However, despite the great potential of these drug delivery systems, most of them display a low resistance to proteases. Here, we report the development and characterization of a new CPP named RICK corresponding to the retro-inverso form of the CADY-K peptide. We show that RICK conserves the main biophysical features of its L-parental homologue and keeps the ability to associate with siRNA in stable peptide-based nanoparticles. Moreover the RICK:siRNA self-assembly prevents siRNA degradation and induces inhibition of gene expression. This new approach consists in a promising strategy for future in vivo application, especially for targeted anticancer treatment (e.g. knock-down of cell cycle proteins).

22 May 2015 in Molecular Imaging and Biology
Verified
Journal Article
Closed access
PDF file
CGCoralie Genevois
Coralie Genevois
OGOlivia Garandeau
Olivia Garandeau
FCFranck Couillaud
Franck Couillaud

1 June 2017 in Journal of Controlled Release
Verified
Journal Article
Closed access
GAGudrun Aldrian
Gudrun Aldrian
AVAnaïs Vaissière
Anaïs Vaissière
KKKaridia Konate
Karidia Konate
QSQuentin Seisel
Quentin Seisel
EVEric Vivès
Eric Vivès
Prisca BoisguérinPrisca Boisguérin
Prisca Boisguérin

1 June 2017 in Biochimica et Biophysica Acta (BBA) - General Subjects
Verified
Journal Article
Open access
LALaurent Adumeau
Laurent Adumeau
CGCoralie Genevois
Coralie Genevois
LRLydia Roudier
Lydia Roudier
CSChristophe Schatz
Christophe Schatz
FCFranck Couillaud
Franck Couillaud
SMStéphane Mornet
Stéphane Mornet
In the context of systematically administered nanomedicines, the physicochemistry of NP surfaces must be controlled as a prerequisite to improve blood circulation time, and passive and active targeting. In particular, there is a real need to develop NP stealth and labelling for both in vivo and microscopic fluorescence imaging in a mice model. We have synthesized NIR/red dually fluorescent silica nanoparticles of 19nm covalently covered by a PEG layer of different grafting density in the brush conformational regime by using a reductive amination reaction. These particles were characterized by TEM, DRIFT, DLS, TGA, ζ potential measurements, UV-vis and fluorescence spectroscopy. Prostate tumors were generated in mice by subcutaneous injection of RM1-CMV-Fluc cells. Tumor growth was monitored by BLI after a D-luciferin injection. Four samples of PEGylated fluorescent NPs were individually intravenously injected into 6 mice (N=6, total 24 mice). Nanoparticle distribution was investigated using in vivo fluorescence reflectance imaging (FRI) over 48h and microscopy imaging was employed to localize the NPs within tumors in vitro. Fluorescent NP accumulation, due to the enhanced permeability and retention (EPR) effect, increases gradually as a function of increased PEG surface grafting density with a huge difference observed for the highest density grafting. For the highest grafting density, a blood circulation time of up to 24h was observed with a strong reduction in uptake by the liver. In vivo experimental results suggest that the biodistribution of NPs is very sensitive to slight variations in surface grafting density when the NPs present a high curvature radius. This study underlines the need to compensate a high curvature radius with a PEG-saturated NP surface to improve blood circulation and accumulation within tumors through the EPR effect. Dually fluorescent NPs PEGylated to saturation display physical properties useful for assessing the susceptibility of tumors to the EPR effect. Control of the physicochemical features of nanoparticle surfaces to improve blood circulation times and monitoring of the EPR effect. This article is part of a Special Issue entitled "Recent Advances in Bionanomaterials" Guest Editor: Dr. Marie-Louise Saboungi and Dr. Samuel D. Bader.

21 March 2016 in Scientific Reports
Verified
Journal Article
Open access
CMClaire Mazzocco
Claire Mazzocco
Giulio FracassoGiulio Fracasso
Giulio Fracasso
CGCoralie Genevois
Coralie Genevois
NDNathalie Dugot-Senant
Nathalie Dugot-Senant
MFMariangela Figini
Mariangela Figini
FCFranck Couillaud
Franck Couillaud
We aimed to evaluate a fluorescent-labeled single chain variable fragment (scFv) of the anti-PSMA antibody as a specific probe for the detection of prostate cancer by in vivo fluorescence imaging. An orthotopic model of prostate cancer was generated by injecting LNCaP cells into the prostate lobe. ScFvD2B, a high affinity anti-PSMA antibody fragment, was labeled using a near-infrared fluorophore to generate a specific imaging probe (X770-scFvD2B). PSMA-unrelated scFv-X770 was used as a control. Probes were injected intravenously into mice with prostate tumors and fluorescence was monitored in vivo by fluorescence molecular tomography (FMT). In vitro assays showed that X770-scFvD2B specifically bound to PSMA and was internalized in PSMA-expressing LNCaP cells. After intravenous injection, X770-scFvD2B was detected in vivo by FMT in the prostate region. On excised prostates the scFv probe co-localized with the cancer cells and was found in PSMA-expressing cells. The PSMA-unrelated scFv used as a control did not label the prostate cancer cells. Our data demonstrate that scFvD2B is a high affinity contrast agent for in vivo detection of PSMA-expressing cells in the prostate. NIR-labeled scFvD2B could thus be further developed as a clinical probe for imaging-guided targeted biopsies.